Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionEnterprise Financial Services Corp
Latest Disclosed Ownership1,472 shares
Latest Disclosed Value $ 205,152
Enterprise Financial Services Corp ownership in GILD / Gilead Sciences, Inc.

On May 5, 2026 - Enterprise Financial Services Corp filed a 13F-HR form disclosing ownership of 1,472 shares of Gilead Sciences, Inc. (CH:GILD) valued at $205,152 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 14, 2022 disclosing 0 shares of Gilead Sciences, Inc..

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F GILEAD SCIENCES COM 375558103 1,472 1,472 205 0.0577
2022-02-14 2021-12-31 13F GILEAD SCIENCES COM 375558103 0 -11,275 -100.00 0 -100.00
2021-11-15 2021-09-30 13F GILEAD SCIENCES COM 375558103 11,275 10,461 1,285.14 788 1,307.14 0.1020
2021-08-16 2021-06-30 13F Gilead Sciences Common Stock 375558103 814 -34 -4.01 56 1.82 0.0090
2021-05-13 2021-03-31 13F Gilead Sciences Common Stock 375558103 848 -55 -6.09 55 3.77 0.0098
2021-02-12 2020-12-31 13F Gilead Sciences Common Stock 375558103 903 -367 -28.90 53 -33.75 0.0101
2020-11-13 2020-09-30 13F Gilead Sciences Common Stock 375558103 1,270 -727 -36.40 80 -47.71 0.0165
2020-08-04 2020-06-30 13F Gilead Sciences Common Stock 375558103 1,997 59 3.04 153 5.52 0.0330
2020-05-15 2020-03-31 13F Gilead Sciences Common Stock 375558103 1,938 756 63.96 145 88.31 0.0366
2020-01-28 2019-12-31 13F Gilead Sciences Common Stock 375558103 1,182 404 51.93 77 57.14 0.0168
2019-10-31 2019-09-30 13F GILEAD SCIENCES COMMON STOCK 375558103 778 -218 -21.89 49 -25.76 0.0112
2019-07-30 2019-06-30 13F Gilead Sciences Common Stock 375558103 996 385 63.01 66 69.23 0.0143
2019-04-26 2019-03-31 13F GILEAD SCIENCES COMMON STOCK 375558103 611 110 21.96 39 25.81 0.0085
2019-01-25 2018-12-31 13F GILEAD SCIENCES COMMON STOCK 375558103 501 -437 -46.59 31 -56.94 0.0196
2018-10-26 2018-09-30 13F GILEAD SCIENCES COMMON STOCK 375558103 938 192 25.74 72 35.85 0.0377
2018-07-27 2018-06-30 13F GILEAD SCIENCES COMMON STOCK 375558103 746 81 12.18 53 6.00 0.0269
2018-04-27 2018-03-31 13F GILEAD SCIENCES COMMON STOCK 375558103 665 37 5.89 50 11.11 0.0257
2018-01-26 2017-12-31 13F GILEAD SCIENCES COMMON STOCK 375558103 628 -200 -24.15 45 -32.84 0.0219
2017-10-27 2017-09-30 13F GILEAD SCIENCES COMMON STOCK 375558103 828 131 18.79 67 36.73 0.0331
2017-07-28 2017-06-30 13F GILEAD SCIENCES COMMON STOCK 375558103 697 75 12.06 49 16.67 0.0245
2017-04-27 2017-03-31 13F GILEAD SCIENCES COMMON STOCK 375558103 622 -257 -29.24 42 -33.33 0.0207
2017-01-26 2016-12-31 13F GILEAD SCIENCES COMMON STOCK 375558103 879 108 14.01 63 3.28 0.0317
2016-10-28 2016-09-30 13F GILEAD SCIENCES COMMON STOCK 375558103 771 111 16.82 61 10.91 0.0345
2016-07-29 2016-06-30 13F GILEAD SCIENCES COMMON STOCK 375558103 660 31 4.93 55 -5.17 0.0324
2016-04-29 2016-03-31 13F GILEAD SCIENCES COMMON STOCK 375558103 629 130 26.05 58 16.00 0.0350
2016-01-29 2015-12-31 13F GILEAD SCIENCES COMMON STOCK 375558103 499 33 7.08 50 8.70 0.0297
2015-10-29 2015-09-30 13F GILEAD SCIENCES COMMON STOCK 375558103 466 87 22.96 46 4.55 0.0294
2015-07-27 2015-06-30 13F GILEAD SCIENCES COMMON STOCK 375558103 379 -306 -44.67 44 -34.33 0.0260
2015-04-29 2015-03-31 13F GILEAD SCIENCES COMMON STOCK 375558103 685 35 5.38 67 9.84 0.0394
2015-01-23 2014-12-31 13F GILEAD SCIENCES COMMON STOCK 375558103 650 -154 -19.15 61 -28.24 0.0369
2014-10-24 2014-09-30 13F GILEAD SCIENCES COMMON STOCK 375558103 804 -94 -10.47 85 13.33 0.0538
2014-07-24 2014-06-30 13F GILEAD SCIENCES COMMON STOCK 375558103 898 -80 -8.18 75 8.70 0.0447
2014-04-24 2014-03-31 13F GILEAD SCIENCES COMMON STOCK 375558103 978 -5,312 -84.45 69 -85.38 0.0424
2014-01-30 2013-12-31 13F GILEAD SCIENCES COMMON STOCK 375558103 6,290 -3,630 -36.59 472 -24.36 0.2737
2013-10-25 2013-09-30 13F GILEAD SCIENCES COMMON STOCK 375558103 9,920 -1,128 -10.21 624 10.25 0.3942
2013-07-25 2013-06-30 13F GILEAD SCIENCES COMMON STOCK 375558103 11,048 11,048 566 0.3883
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.